The global Fractional Flow Reserve Market size is expected to
reach USD 1.20 billion by 2026, according to a new report by Grand View
Research, Inc. expanding at a CAGR of 10.4% over the forecast period. widening
base of cardiovascular diseases coupled with mounting cases of diabetes in
developed as well as developing economies is escalating the growth of the
market. Furthermore, launch of novel devices in fractional flow reserve (FFR)
market such as guidewires and monitoring systems are also anticipated to aid
market growth. For instance, in May 2019, Philips launched IntraSight
interventional applications platform. This platform offers comprehensive unit
of IVUS, FFR, IFR and co-registration modalities to speed up the routine
procedures and simplify complex interventions.
In an independent study by SCAI, in 2019 it was observed that
FFR possess the capability to decide the treatment plan for Acute Coronary
Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention)
or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the
physicians and provide effective treatment plan to patients, thereby increasing
adoption of the same in coming five years.
Moreover, consolidation activities, such as acquisition of St.
Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular
devices market, is likely to keep the market highly competitive and thereby,
augur well for the overall market.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/fractional-flow-reserve-ffr-market
https://www.grandviewresearch.com/industry-analysis/fractional-flow-reserve-ffr-market
Further key findings from the report suggest:
- FFR
monitoring systems accounted for significant share of over 40.0% in 2018
owing to the extensive usage in single and multiple vessel CAD.
- FFR
guidewires is expected grow at a profitable growth rate over the forecast
period due to increase in fractional flow reserve procedures conducted
globally.
- North
America held the significant share of FFR devices industry as of 2018, due
to the increased investment in R&D by the medical device companies.
For instance, a bill was approved by the U.S. congress in May 2018 via
which an individual can try unproven medical aids comprising drugs,
medications and devices in case of severe illness.
- Asia
Pacific regional FFR industry is anticipated to witness major growth due
to rising healthcare spending and rise in diabetes cases in countries such
as China and India.
- Some
of the key companies operating in the fractional flow reserve market are
OPSENS Medical, Abbott Laboratories, Boston Scientific, and Bracco S.p.A.
among others.
- The
industry participants are engaged in extensive research activities to
develop novel FFR devices for diagnosis of cardiac disorders.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment